Latest OMX Ventures News
Sep 28, 2021
Preclinical neuroscience company Delix Therapeutics, today announced the closing of a USD 70 million Series A financing round. The round was led by ARTIS Ventures, RA Capital Management, and founding investor OMX Ventures, with participation from a diverse syndicate of life sciences and psychedelic investment funds.
OMX Ventures Team
2 Team Members
OMX Ventures has 2 team members, including current Managing Director, Craig Asher.